Ammar Sabilarrohman

Advancing the Frontier: The Critical Role of Human Genetics and Genomics in National Policy advancing-the-frontier-the-critical-role-of-human-genetics-and-genomics-in-national-policy

Advancing the Frontier: The Critical Role of Human Genetics and Genomics in National Policy

Ammar Sabilarrohman August 19, 2026

In an era defined by rapid scientific breakthroughs, the fields of human genetics and genomics stand at...

Ziresovir Poised to Revolutionize RSV Treatment as FDA Greenlights Crucial US Clinical Trial ziresovir-poised-to-revolutionize-rsv-treatment-as-fda-greenlights-crucial-us-clinical-trial

Ziresovir Poised to Revolutionize RSV Treatment as FDA Greenlights Crucial US Clinical Trial

Ammar Sabilarrohman August 19, 2026

Shanghai Ark Biopharmaceutical (ArkBio) has achieved a significant milestone in its quest to combat Respiratory Syncytial Virus...

Bridging the Climate-Health Gap: WHO and the Netherlands Forge New Path for Global Resilience bridging-the-climate-health-gap-who-and-the-netherlands-forge-new-path-for-global-resilience

Bridging the Climate-Health Gap: WHO and the Netherlands Forge New Path for Global Resilience

Ammar Sabilarrohman August 18, 2026

By Global Health Correspondent In an era where the environmental crisis is increasingly manifesting as a public...

The Agentic Frontier: Schrödinger and BMS Redefine Trillion-Scale Drug Discovery with Bunsen the-agentic-frontier-schrodinger-and-bms-redefine-trillion-scale-drug-discovery-with-bunsen

the-agentic-frontier-schrodinger-and-bms-redefine-trillion-scale-drug-discovery-with-bunsen

The Agentic Frontier: Schrödinger and BMS Redefine Trillion-Scale Drug Discovery with Bunsen

Ammar Sabilarrohman August 18, 2026

In a landmark shift for the pharmaceutical industry, Schrödinger, the pioneer of physics-based computational drug discovery, has...

Unlocking Cellular Powerhouses: Salk Institute Identifies Estrogen-Related Receptors as Key to Muscle Metabolism and Repair unlocking-cellular-powerhouses-salk-institute-identifies-estrogen-related-receptors-as-key-to-muscle-metabolism-and-repair

Unlocking Cellular Powerhouses: Salk Institute Identifies Estrogen-Related Receptors as Key to Muscle Metabolism and Repair

Ammar Sabilarrohman August 17, 2026

LA JOLLA, CA – May 12, 2025 – In a significant stride towards combating debilitating metabolic disorders...

Strengthening Lebanon’s Health Infrastructure: A Strategic €10 Million Partnership Between WHO and EIB Global strengthening-lebanons-health-infrastructure-a-strategic-e10-million-partnership-between-who-and-eib-global-1

strengthening-lebanons-health-infrastructure-a-strategic-e10-million-partnership-between-who-and-eib-global-1

Strengthening Lebanon’s Health Infrastructure: A Strategic €10 Million Partnership Between WHO and EIB Global

Ammar Sabilarrohman August 17, 2026

LUXEMBOURG – In a significant move to fortify the resilience of Lebanon’s crumbling healthcare system, the World...

The Great Retrenchment: Evaluating the Dismantling of U.S. Global Health Infrastructure the-great-retrenchment-evaluating-the-dismantling-of-u-s-global-health-infrastructure

The Great Retrenchment: Evaluating the Dismantling of U.S. Global Health Infrastructure

Ammar Sabilarrohman August 16, 2026

Editorial Note: Originally published in May 2025, this report has been significantly updated to reflect the evolving...

Breakthrough Research Reveals Genetics as Potent Factor in Secondary Cancers for Childhood Survivors breakthrough-research-reveals-genetics-as-potent-factor-in-secondary-cancers-for-childhood-survivors

Breakthrough Research Reveals Genetics as Potent Factor in Secondary Cancers for Childhood Survivors

Ammar Sabilarrohman August 16, 2026

MEMPHIS, TN – [Date] – In a landmark study that promises to redefine long-term care for childhood...

PhenoNet Secures FDA Green Light for Pivotal Phase III Trial of Novel Alzheimer’s Treatment, PHENOGENE-1A phenonet-secures-fda-green-light-for-pivotal-phase-iii-trial-of-novel-alzheimers-treatment-phenogene-1a

PhenoNet Secures FDA Green Light for Pivotal Phase III Trial of Novel Alzheimer’s Treatment, PHENOGENE-1A

Ammar Sabilarrohman August 14, 2026

San Francisco, CA – [Insert Date] – PhenoNet, a biopharmaceutical company dedicated to pioneering treatments for neurodegenerative...

Beyond Aesthetics: The Science and Practice of Building Functional Arm Strength Through Yoga beyond-aesthetics-the-science-and-practice-of-building-functional-arm-strength-through-yoga

Beyond Aesthetics: The Science and Practice of Building Functional Arm Strength Through Yoga

Ammar Sabilarrohman August 14, 2026

Published: August 14, 2026 In the modern fitness landscape, the pursuit of arm strength is frequently relegated...

Advancing the Frontier: The Critical Role of Human Genetics and Genomics in National Policy

Ziresovir Poised to Revolutionize RSV Treatment as FDA Greenlights Crucial US Clinical Trial

Bridging the Climate-Health Gap: WHO and the Netherlands Forge New Path for Global Resilience

The Agentic Frontier: Schrödinger and BMS Redefine Trillion-Scale Drug Discovery with Bunsen

Strengthening Lebanon’s Health Infrastructure: A Strategic €10 Million Partnership Between WHO and EIB Global

The Great Retrenchment: Evaluating the Dismantling of U.S. Global Health Infrastructure

Breakthrough Research Reveals Genetics as Potent Factor in Secondary Cancers for Childhood Survivors

PhenoNet Secures FDA Green Light for Pivotal Phase III Trial of Novel Alzheimer’s Treatment, PHENOGENE-1A

Beyond Aesthetics: The Science and Practice of Building Functional Arm Strength Through Yoga

You may have missed

The Great Insurance Debate: Dissecting the Role of Health Insurers in America’s Fiscal Crisis

Beyond the Cream: How a Father’s Quest for Relief Sparked a Skincare Revolution

Salk Scientists Unveil Estrogen-Related Receptors as Key to Unlocking Energy Metabolism and Combating Muscle Fatigue

The Architecture of Hope: Mapping the Centuries-Long Evolution of Breast Cancer Treatment